Indaptus Therapeutics (INDP) Earnings Date & Reports

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INDP is expected to report earnings to fall 51.35% to -18 cents per share on May 08

Indaptus Therapeutics INDP Stock Earnings Reports

Q1'25

Est.

$-0.18

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.16

Q2'24

Beat

by $0.11

Q1'24

Beat

by $0.12

The last earnings report on March 13 showed earnings per share of -37 cents, beating the estimate of -46 cents. With 72.18K shares outstanding, the current market capitalization sits at 7.79M.

View a ticker or compare two or three

Compare

INDP